Mouwasat Medical Services Company (TADAWUL:4002)
Saudi Arabia · Delayed Price · Currency is SAR 62.75
+0.35 (0.56%)
Jul 2, 2026, 3:19 PM AST
TADAWUL:4002 Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, TADAWUL:4002 stock has a consensus rating of "Buy" and an average price target of SAR 85.85. The average 1-year stock price forecast is 36.81% higher than the current stock price, while the lowest is SAR 63.00 (+0.40%) and the highest is SAR 118.00 (+88.05%).
Price Target: SAR 85.85 (+36.81%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for TADAWUL:4002 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 3 | 5 | 5 | 6 |
| Buy | 1 | 1 | 1 | 1 | 0 | 1 |
| Hold | 5 | 5 | 6 | 5 | 6 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 1 | 1 | 0 |
| Total | 10 | 10 | 10 | 12 | 12 | 12 |
Financial Forecast
Revenue This Year
3.62B
from 3.22B
Increased by 12.22%
Revenue Next Year
3.98B
from 3.62B
Increased by 10.12%
EPS This Year
4.25
from 4.11
Increased by 3.52%
EPS Next Year
4.56
from 4.25
Increased by 7.27%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SAR.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.7B | ||
| Avg | 3.6B | ||
| Low | 3.5B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 14.8% | ||
| Avg | 12.2% | ||
| Low | 8.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4.46 | ||
| Avg | 4.25 | ||
| Low | 4.05 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 8.5% | ||
| Avg | 3.5% | ||
| Low | -1.5% |